# In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

> **NCT00354536** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 60 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** GSK716155 subcutaneous injections
- **BIOLOGICAL:** placebo injection

## Key facts

- **NCT ID:** NCT00354536
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2016-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354536, "In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00354536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*